Fig. 2From: MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosisKaplan-Meier analyses of OS and RFS in 98 patients with HCC in high and low expression levels of miR-214-3p. a OS; b RFS. HCC patients were divided into miR-214-3p high and low expression groups based on the median fold-change valuesBack to article page